Social Media Ideas for Cinclus Pharma

<![CDATA[Merck KGaA, Darmstadt, Germany, Acquires Silence Therapeutics for $1.3 Billion ]]>

<![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...

<![CDATA[Roundup: Sling Therapeutics Closes $123 Million Series C Financing, Circle Pharma Announces $92.5 Million Se...

<![CDATA[Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifyin...

Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Anonymous (not verified) Sat, 09/19/2026 - 21:55 field_thread_url https://cafepharma.com/boards/threads/aurinia-pharmaceuticals.652...

Kiniksa

Kiniksa Anonymous (not verified) Mon, 10/05/2026 - 04:07 field_thread_url https://cafepharma.com/boards/threads/kiniksa.658756/ board na...

<![CDATA[Viatris Acquires Pacira BioSciences for $1.65 Billion ]]>

Pharmacosmos Therapeutics

Pharmacosmos Therapeutics Anonymous (not verified) Fri, 10/16/2026 - 10:12 field_thread_url https://cafepharma.com/boards/threads/pharmacosmos-therapeutics...

<![CDATA[Caribou Biosciences Discontinues Development for Vispa-cel & CB-011 CAR-T Cell Therapy Programs ]]>

<![CDATA[Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreeme...

<![CDATA[Roundup: CSL & Alentis Enter Global Partnership, Jiangsu Nhwa Enters Global Licensing Deal with Somniver...

Kiniksa

Kiniksa Anonymous (not verified) Thu, 09/17/2026 - 18:54 field_thread_url https://cafepharma.com/boards/threads/kiniksa.658756/ board na...

Cumberland Pharmaceuticals stock tumbles on trial results

Kura spins diabetes work into a Lilly-backed biotech startup

Caspian Therapeutics aims to develop menin inhibitors, which have proven effective against leukemia, for diabetes and other cardiometabolic conditions.

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

<![CDATA[Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Ente...

<![CDATA[M&A Roundup: Lisata Therapeutics Acquires Marea Therapeutics, mAbxience Enters Collaboration with Sandoz...

<![CDATA[Roundup: Orbis Enters $1.4 Billion Partnership with Novo, Dualitas Therapeutics Enters Research collaboratio...

Merck KGaA’s $1.1B Silence Therapeutics Buyout Brings RNA Drug for Rare Blood Cancer

The Silence Therapeutics acquisition gives Merck KGaA a drug ready for a pivotal test in the blood disorder polycythemia vera. Silence’s RNA therapy offers a different approach and...

<![CDATA[Roundup: AbbVie & Iambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM ]]>

Dianthus gains new Buy from Citi on multi-blockbuster potential for lead drug

An orexin drug’s ‘proof-of-concept’ in ADHD; Cue’s ‘unwarranted’ share slide

Alkermes’ results heightened anticipation for a coming readout in 2027. Elsewhere, AbbVie leaned into AI drug discovery and the FDA expanded use of Eli Lilly’s breast cancer pill.

<![CDATA[Aptar and Aceso Therapeutics Enter Collaboration for Cystic Fibrosis Therapy ]]>

Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month

PRNewswireMumbai (Maharashtra) [India], October 1: Piramal Pharma Solutions ('PPS'), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal...